Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

531 results about "Protein molecules" patented technology

Comogolov GCN protein ligand affinity prediction method

PendingCN118969062AEfficient characterization of interactionsGuaranteed expressivenessMolecular designChemical machine learningVirtual screeningActivation function
The invention discloses a method for predicting affinity of a Comogolov GCN protein ligand, which is characterized in that a graph neural network is associated with the interaction between a ligand and a protein (DTI) to predict the affinity in the DTI. When the affinity is predicted, a Kolmogorov network (KAN) is introduced after GCN stacking so as to effectively judge which subsequences in the protein are more likely to bind to the ligand. According to the method, GCN is used for extracting abstract information of ligands and protein molecules, so that characterization of interaction of the protein and the ligands is more efficient. The KAN places the activation function on the edge (weight) and makes it learnable. Thus, the calculation of the KAN is reexpressed by processing the input by using different basis functions or activating the input, and then linearly combining the output. For DTI, the recoding based on KAN ensures the expressive force of a GCN model during virtual screening, and can also improve the interpretability of a prediction model and enhance the flexibility of the model.
Owner:NANJING UNIV OF POSTS & TELECOMM

Drug target binding affinity prediction method based on multi-modal data fusion enhancement

The invention provides a drug target binding affinity prediction method based on multi-modal data fusion. The method comprises the following steps: firstly, extracting sequence feature information of drug SMILES and target FASTA, then constructing an affinity graph, modeling drug molecules and target protein molecules into an undirected graph, and extracting molecular-level features of atoms, bonds, residues and contact. And fusing the hierarchical graph structure information of the affinity graph and the molecular graph to obtain the graph structure feature representation of the drug-target spot. The sequence feature information and the graph structure feature representation are further fused by using intramolecular and intermolecular attention fusion mechanisms. And finally, performing affinity prediction by using the fused features, and outputting a drug-target binding affinity score. According to the method, sequence and structural information are effectively fused, the accuracy of drug target affinity prediction is improved, and the problems of insufficient information fusion and insufficient structural information utilization in an existing method are solved.
Owner:WUHAN UNIV OF SCI & TECH

Targeting exosome capable of delivering nucleic acid drugs and preparation method thereof

The invention relates to the technical field of biological medicine, and provides a targeting exosome capable of delivering nucleic acid drugs and a preparation method of the targeting exosome. The exosome comprises a fusion polypeptide, the fusion polypeptide comprises a targeting protein molecule, an exosome transmembrane protein and a nucleic acid binding domain, and the exosome can load a nucleic acid molecule through binding of the nucleic acid binding domain. According to the invention, engineering modification is carried out on the exosome, so that nucleic acid molecules can be efficiently loaded into the exosome, and meanwhile, the exosome is endowed with the capability of targeting to specific target cells, tissues and organs.
Owner:P S K BIOSCIENCE CO LTD

A phycocyanin-collagen composite hydrogel and its preparation method and application

The present invention provides a phycocyanin-collagen composite hydrogel and its preparation method and application. The present invention utilizes transglutaminase to catalyze the combination of phycocyanin and collagen to form a new, more stable collagen; transglutaminase acts between protein molecules, utilizes lysine and glutamic acid in phycocyanin and collagen to transfer acyl groups, and cross-links to form new chemical bonds, thereby enhancing the binding strength of phycocyanin and collagen; the hydrogel prepared by the present invention can be used to prepare medical materials and combined with skin injury sites to solve the problem that traditional dressings are easy to adhere to wounds and easily penetrated by tissue fluid and become infected. In addition to ensuring basic air permeability, it reduces the adhesion of the dressing, increases moisture retention and antioxidant properties, and avoids secondary damage when replacing a new dressing. The hydrogel prepared by the present invention has a certain antioxidant capacity and can be used to prepare products with antioxidant effects.
Owner:SHANDONG UNIV OF SCI & TECH +1

Nylon 6 nanofiber virus-removing filtering membrane as well as preparation method and application thereof

The invention provides a nylon 6 nanofiber virus-removing filtering membrane and a preparation method and application thereof.The nylon 6 nanofiber virus-removing filtering membrane comprises a base material and a nylon 6 nanofiber membrane compounded to the surface of the base material, the average pore size of the virus-removing filtering membrane is 20 nm, the virus-removing filtering membrane plays a role in blocking parvoviruses, the surface of the virus-removing filtering membrane is charged, and the surface of the virus-removing filtering membrane is not prone to being damaged. Proteins with the same charges on the surface can be prevented from adhering to the surface of the fiber. In the preparation process of the virus-removing filtering membrane, the nylon 6 nanofibers with a certain diameter range are selected and compounded on the surface of the base material in a stable dispersion state, the uniform microporous virus-removing filtering membrane is prepared, the effect that parvoviruses are blocked and protein molecules are not easily intercepted is achieved, the hydrophilicity of the nylon 6 nanofibers is relatively good, and the virus-removing filtering membrane has a good application prospect. The non-specific adsorption of the filtering membrane on the protein is reduced; the nylon 6 nanofiber virus-removing filtering membrane can be applied to the field of biological medicine products, and has important significance on separation and purification of biological preparations.
Owner:WUHAN WEICHEN TECH CO LTD +1

Organic molecule cytoplasm delivery carrier as well as preparation method and application thereof

The invention provides an organic molecule cytoplasm delivery carrier as well as a preparation method and application thereof, the compound for cytoplasm delivery has the characteristic of fat-soluble aggregation, and can form electrostatic adsorption with small molecule protein goods such as RNase A (13.7 KDa), Trypsin (24KDa) and Saporin (32.8 KDa), medium molecule protein goods such as HRP (40KDa) and macromolecular protein goods such as beta-Gal (430KDa), so that the compound for cytoplasm delivery can be used for preparing a lipid-soluble protein carrier. And furthermore, transmembrane transportation is formed through the strong fat solubility property, so that the protection and intracellular delivery of carried protein molecules are realized. According to the delivery mechanism, cargo molecules can quickly penetrate through cell membranes, and carried protein molecules can enter cytoplasm to exert functions without release operation. Development of the organic molecule cytoplasm delivery carrier is expected to assist potential protein therapies with low bioavailability and off-target toxicity to complete clinical transformation, which is crucial to tumor therapy, gene therapy and the like requiring precise local administration.
Owner:BEIJING NORMAL UNIV AT ZHUHAI

Monkey pox virus multi-antigen monovalent vaccine and application thereof

The invention provides a monkey pox virus multi-antigen monovalent vaccine and application thereof. Specifically, the invention provides a monkey pox virus monovalent multi-antigen fusion protein, and the fusion protein comprises a first fusion protein element containing A35R and M1R proteins and a second fusion protein element containing A29L and B6R proteins from an N terminal to a C terminal. According to the invention, A35R, M1R, A29L and B6R are subjected to reasonable antigen combination to design a protein molecule, and the protein molecule is prepared into a monovalent mRNA vaccine. Experimental results show that the mRNA vaccine provided by the invention can ensure high-efficiency expression of target protein in vivo and can induce a high-level neutralizing antibody.
Owner:NOVOPROTEIN SCI INC

Novel coronavirus variation analysis method

The invention discloses a novel coronavirus variation analysis method, belongs to the technical field of virus analysis and detection, and aims to solve the problem of how to quickly analyze virus variation in the prior art. The main method comprises the following steps: carrying out nucleic acid extraction and detection recheck on the novel coronavirus; carrying out whole genome targeted amplification on the novel coronavirus; carrying out whole genome sequencing on the novel coronavirus; carrying out genetic typing on the novel coronavirus; performing sequence quality evaluation on the obtained fasta file, and screening the sequence; and carrying out nucleotide and amino acid mutation site analysis on the screened high-quality sequence. According to the invention, the strain variation rule is analyzed from gene and protein molecule levels, and the influence of key variation on virus propagation and adaptability can be predicted according to the variation rule; tools used in the variation method are all existing tools, the actual effect can be well improved, and rapid preliminary variation analysis is provided.
Owner:SHENZHEN INT TRAVEL HEALTHCARE CENT

Plug-and-play Mi3 protein nanocage fusion protein with VNP6 tag and preparation method and application thereof

The invention provides a plug-and-play Mi3 protein nanocage fusion protein with a VNP6 tag and a preparation method and application of the plug-and-play Mi3 protein nanocage fusion protein, the fusion protein comprises the VNP6 tag, a SpyCatch003 component, a Mi3 protein nanocage and a functional protein sequence, and the VNP6 tag is located at the N end of the fusion protein. The VNP6 peptide sequence or the variant thereof is utilized to induce a vesicle or vesicle-like structure beneficial to protein folding and stabilization in escherichia coli, so that the correct folding rate and activity of recombinant protein are improved while the overall intracellular molecular crowding effect is relieved. The core idea of the invention lies in that the internal structure of cells is regulated at low temperature, and the internal microenvironment of an escherichia coli expression system is optimized, so that protein molecules under high expression load can obtain more reasonable spatial distribution, and the problems of misfolding and aggregation caused by molecular crowding are reduced.
Owner:XIAN JIAOTONG LIVERPOOL UNIV

Oxygen-carrying protein molecule as well as preparation method and application thereof

The invention provides an oxygen-carrying protein molecule and a preparation method and application thereof, and relates to the technical field of functional protein preparation, the oxygen-carrying protein molecule comprises at least one cysteine part and at least one histidine part, the cysteine part comprises acetyl or ethyl maleoyl, and the histidine part comprises histidine. The histidine moiety includes a benzimidazole derivative group. The benzimidazole derivative is adopted as an auxiliary molecule and participates in the modification process of the sulfydryl modified compound on the hemoglobin, the modification site selectivity is improved, the conformational change is reduced, and the modification degree is accurately controlled, so that the oxygen binding force P50 of the modified hemoglobin is effectively improved.
Owner:GUANGDONG LONGKANG FANGCHENG MEDICAL EQUIPMENT CO LTD

Glucan-based HRP-goat anti-mouse IgG labeled antibody and preparation method thereof

The invention discloses a dextran-based HRP-goat anti-mouse IgG labeled antibody and a preparation method thereof, and the preparation method is characterized by comprising the following steps: S1, oxidizing dextran to obtain aldehyde group-containing dextran; s2, carrying out polymerization on the dextran containing the aldehyde group and horse radish peroxidase, so as to obtain a horse radish peroxidase polymer; s3, performing desalination and ultrafiltration on the horse radish peroxidase polymer to obtain an ultrafiltration product I; s4, connecting a goat anti-mouse IgG antibody to the ultrafiltration product I to obtain oxidized glucan coupled with goat anti-mouse IgG and HRP enzyme; and S5, purifying the oxidized dextran of the product coupled with the goat anti-mouse IgG and the HRP enzyme, so as to obtain the dextran coupled HRP-goat anti-mouse IgG labeled antibody. The dextran product obtained by the invention is wide in molecular weight coverage, different molecular weights can be selected to design polymer substances with different sizes, the number of aldehyde groups can be controlled to control coupling of different numbers of protein molecules under the same molecular weight, and the signal intensity is easy to control.
Owner:KAQIU (JIANGSU) BIOTECHNOLOGY CO LTD

Application of natural protein molecule in preparation of medicine for resisting Parkinson's syndrome

The invention belongs to the technical field of biological medicine, discloses application of a natural protein molecule in preparation of a medicine for resisting Parkinson's syndrome, and particularly discloses a protein molecule which comprises A-B, A comprises A-chain polypeptide or functional variants of the A-chain polypeptide, and B comprises A-chain polypeptide or functional variants of the A-chain polypeptide. B comprises a B-chain polypeptide or a functional variant thereof; the A is in disulfide bridging with the B; the amino acid sequence of the A-chain polypeptide is as shown in SEQ ID NO: 1; the amino acid sequence of the B-chain polypeptide is as shown in SEQ ID NO: 2. The invention discloses a natural protein molecule and application thereof in treatment and / or prevention of Parkinson's syndrome for the first time, the protein molecule can show antioxidant capacity by activating GSH in cells and inhibiting ROS formation, and meanwhile, the protein molecule can also show antioxidant capacity by activating mitochondrial activity and anti-GFAP activity in an MPP-induced brain injury environment, so that the protein molecule can be used for treating and / or preventing Parkinson's syndrome. The natural protein molecule has the medical effect of relieving and treating Parkinson's syndrome.
Owner:THE HONG KONG UNIV OF SCI & TECH

Potentiometric OECT biosensor and preparation method and application thereof

The invention discloses a potentiometric OECT biosensor as well as a preparation method and application thereof, and belongs to the technical field of organic electrochemical sensing. The potentiometric OECT biosensor comprises a device module and a sensing module, the device module comprises a substrate, and a source electrode, a grid electrode and a first floating gate are arranged on the substrate; a semiconductor channel is arranged on the source electrode, and a drain electrode is arranged on the semiconductor channel; a grid control grid is arranged on the grid; a hydrogel electrolyte layer is arranged at the tops of the substrate, the drain electrode, the grid-control grid electrode and the first floating gate; the sensing module adopts an electrode plate; the electrode plate comprises a gold electrode, an Ag / AgCl electrode and a carbon electrode; the gold electrode serves as a sensing grid electrode, an SAM connecting layer, targeted protein molecules and a shielding layer are arranged on the gold electrode, and when the biosensor works, an electrolyte layer is arranged at the top of the sensing module, and the Ag / AgCl electrode serves as a second floating grid; the first floating gate and the second floating gate are connected through a wire. The potentiometric OECT biosensor is high in detection sensitivity and high in response speed, and can meet clinical requirements on rapid and accurate detection.
Owner:XI AN JIAOTONG UNIV

Identification of binding sites in protein structures

In one aspect, a method is provided for identifying a residue in a particular conformation of a protein molecule that is capable of forming a stable bond between a compound and the protein molecule. The method can include identifying one or more residues from the conformation of the protein molecule to include in a perturbation set, the one or more residues exhibiting a protection factor that satisfies one or more thresholds. One or more residues may be excluded from the perturbation set based at least on the spatial arrangement and / or orientation of the one or more residues. One or more rounds of molecular dynamics simulations may be performed, the results of which are indicative of interactions between the compound and the residues in the perturbation set. The residues in the perturbation set may be identified as forming a stable binding between the compound and the protein molecule based at least on the results of the molecular dynamics simulation.
Owner:GENENTECH INC

IL-12-CD137 chimeric protein, function-enhanced engineered NK cell as well as preparation and application of IL-12-CD137 chimeric protein and function-enhanced engineered NK cell

The invention belongs to the technical field of bioengineering, and particularly relates to an IL-12-CD137 chimeric protein, a function-enhanced engineered NK cell, and preparation and application thereof. The IL-12-CD137 chimeric protein comprises a signal peptide, an IL-12a protein molecule, a CD137 transmembrane structural domain and a CD137 intracellular structural domain, and has an amino acid sequence as shown in SEQ ID NO: 1. According to the function-enhanced engineered NK cell, the IL-12-CD137 chimeric protein sequence is introduced into an original NK cell, the function-enhanced engineered NK cell expressing Chime-IL12-CD137 is obtained, the amplification capacity and killing capacity of the NK cell can be enhanced, and the function-enhanced engineered NK cell is applied to treatment of tumor and virus-infected diseases of companion animals for the first time.
Owner:GUOKE MINGYAO (SHANDONG) MEDICAL TECHNOLOGY CO LTD

Prediction model for lung squamous cell carcinoma

The invention relates to a prediction model for lung squamous cell carcinoma, and belongs to the technical field of disease prediction. On the basis of proteomics, protein molecule changes with specific execution functions in the lung squamous cell carcinoma occurrence process are screened, and a lung squamous cell carcinoma occurrence prediction model is constructed in combination with multiple machine learning models and public data. The prediction model for lung squamous cell carcinoma occurrence comprises six prediction factors: DDAH1, ATP11A, NME3, PON2, SLC1A5 and LPCAT1, and the prediction effectiveness (AUC value) of the prediction model can reach 97.6% and is higher than the prediction AUC value of a single factor.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Enzyme cascade reaction system for nucleic acid and protein molecule detection and application

The invention relates to the technical field of biological detection, and provides an enzyme cascade reaction system for nucleic acid and protein molecule detection, which comprises a BER endonuclease and an Argonaute endonuclease, wherein the BER endonuclease is selected from one or more of APE1, FEN1, Fpg, UDG and T7 endonuclease, and the Argonaute endonuclease is selected from one or more of pfAgo, CpAgo, CbAgo, TtAgo, RasAgo, MjAgo and NgAgo. The invention further provides a nucleic acid and protein molecule detection method adopting the system and application of the system in preparation of products for detecting sample target nucleic acid and target protein molecules. According to the present invention, by using the synergistic enzyme activity of APE1 and PfAgo in the enzyme cascade reaction system, the real-time detection of the nucleic acid and the protein biomarker without pre-amplification can be achieved within 45 min;
Owner:ZHEJIANG UNIV

Binding Analysis Of Protein Molecule And Ligand Molecule

According to implementations of the subject matter described herein, a solution for molecular binding analysis is provided. In the solution, a first feature representation determined based on a structure of a ligand molecule may be obtained, and a second feature representation determined based on a structure of a protein molecule may be obtained. A third feature representation of a complex structure may be determined, wherein the complex structure is built based on the protein molecule and the ligand molecule. The first feature representation, the second feature representation and the third feature representation may be used to generate an aggregate feature representation so as to determine evaluation information on the binding between the ligand molecule and the protein molecule. The evaluation information may indicate the effectiveness of the binding or indicate the affinity of a binding pose of the binding. Thereby, more efficient and accurate binding analysis can be realized.
Owner:MICROSOFT TECHNOLOGY LICENSING LLC

Gene sequence construct for gene therapy for HIV infection

The present invention relates to a gene sequence construct for gene therapy for HIV infection. The gene sequence construct is constructed by means of sequentially connecting, via a coding sequence of a linker polypeptide, a gene coding sequence of a variable region scFv in each light chain and heavy chain of a monoclonal antibody against antigens at different binding sites involved in the different steps of HIV infection of a human CD4+ T cell, a gene coding sequence of a variable region scFv in each light chain and heavy chain of a monoclonal antibody bound to a human CD4 receptor site, a gene coding sequence of an Fc fragment in a human IgG constant region, and a gene coding sequence of a polypeptide for inhibiting the fusion of HIV and a CD4+ T cell membrane, and by placing the connected gene coding sequences downstream of a promoter and a secretion signal peptide coding sequence, thereby expressing a single-gene-encoded secretion-type antibody-like protein molecule. The recombinant single-gene construct can be conveniently introduced into a target tissue cell via a viral vector, and the expressed secretion-type antibody-like protein molecule has multi-antigen tropism, can realize the efficient and broad-spectrum blockade of the HIV infection process on a human CD4+ T cell by means of binding to multiple binding sites involved in the different steps of HIV infection of the human CD4+ T cell, and effectively avoids the loss of the ability to inhibit an HIV infection due to an HIV escape mutation, thereby achieving a long-term or even permanent treatment effect on HIV infection by means of a single injection.
Owner:KANGLIN BIOTECHNOLOGY (HANGZHOU) CO LTD

Preparation method of ketogenic coffee solid beverage

The invention relates to the technical field of preparation of solid beverages, discloses a preparation method of a ketogenic solid beverage, and provides active high-protein cream powder, protein is modified through hydroxypropyl distarch sodium phosphate under the action of thermal induction and is covalently grafted with fructo-oligosaccharide, a structure with relatively high stability is formed after grafting, and the ketogenic solid beverage is prepared. And protein molecules are not easy to gather together. According to the present invention, the nutrition level of the product is further enriched, the absorption of the nutrition of each component by the human body is easily achieved, the malnutrition problem caused by the ketogenic diet is avoided, the unpleasant taste caused by the addition of fat and protein is avoided through the reasonable matching of the components, and the brewing property of the solid beverage is improved through the improvement of the active high-protein cream powder; the obtained ketogenic solid beverage has the characteristics of balanced nutrition, good flavor, stable property and easiness in storage.
Owner:GUANGDONG SIJIYOUMEI IND CO LTD

Application of ICOSL agonist in preparation of vaccine

The invention discloses an application of an ICOSL agonist in preparation of a vaccine, and discovers that under the condition of follicular helper T cell (TFH) defect, ICOS protein is used as the ICOSL protein agonist, and a nanoparticle vaccine coupled with the ICOSL agonist can activate ICOSL molecules and directly act on ICOSL to promote B cell proliferation and anti-apoptosis related gene expression. Antibody reaction and antibody secreting cell differentiation and proliferation can be efficiently promoted; according to the present invention, the ICOS protein-coupled vaccine is prepared by using the ICOS protein as the carrier, and the coupled ICOS protein molecule targets the ICOSL signal channel, such that the strong protection effect is provided in the anti-new crown and HIV virus vaccines, and the good immune effect is provided especially for the immunodeficiency / insufficiency population.
Owner:SUN YAT SEN UNIV

Cysteine protease structural domain mediated protein C-terminal selective modification method

The invention relates to a cysteine protease structural domain mediated protein C-terminal selective modification method. The method comprises the following steps: adding a nucleophilic reagent, a catalyst and a cysteine protease allosteric activator into a target protein fused with a cysteine protease structural domain (CPD) as shown in a formula (I), and releasing a C-terminal modified target protein while inducing CPD splitting decomposition. The invention also provides a CPD-catalyzed proteolysis method and a C-terminal modification conversion method on the basis of the C-terminal modification. The method disclosed by the invention has high flexibility and has a huge application prospect in C-terminal modification of protein molecules. # imgabs0 #
Owner:SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES

Preparation method of high-performance soybean protein emulsion film

The invention relates to a preparation method of a high-performance soybean protein emulsion film, which comprises the step of carrying out fibrosis denaturation on soybean protein by adopting an acetic acid-water binary solution, so that the hydrophobic property, the film-forming ability and the environmental interference resistance of the soybean protein can be remarkably improved. And further starting from a protein self-assembly fibrosis principle and a protein film forming theory, a soybean protein-based biological membrane with certain mechanical strength and flexibility is constructed through self-assembly fibrosis denaturation of protein molecules in an aqueous solution, so that the problems of poor mechanical property and high solubility of the existing protein-based biological membrane are effectively solved.
Owner:ZHEJIANG UNIV OF SCI & TECH

Anti-hardening protein bar suitable for cold conditions and preparation method thereof

The invention discloses an anti-hardening protein bar suitable for cold conditions and a preparation method thereof, and belongs to the technical field of food processing. In order to solve the problems of texture hardening and mouthfeel deterioration caused by aggregation and crosslinking of protein molecules in the existing protein bar under a cold condition, the invention provides a method for organically combining specific plant proteins (soybean protein, quinoa protein, winter rapeseed protein and pea protein) rich in antifreeze peptide with antifreeze polysaccharide; the protein bar which can effectively resist hardening and keep good texture and nutritional characteristics in a cold environment is prepared through the processes of extrusion puffing, precise mixing, forming and the like, so that the application of the product in the fields of exercise and fitness, outdoor exploration, emergency storage and the like is expanded, and the market competitiveness of the protein bar is enhanced.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY

Improved cell-targeting binding molecule

The invention relates to a therapeutic combination, comprising a first proteinaceous molecule comprising a first binding site for binding to a first epitope of a first cell-surface molecule, the first proteinaceous molecule provided with at least one saponin covalently bound to an amino-acid residue of said first proteinaceous molecule, and comprising a second pharmaceutical composition comprising a second proteinaceous molecule different from the first proteinaceous molecule, the second proteinaceous molecule comprising a second binding site for binding to a second epitope of a second cell-surface molecule different from the first cell-surface molecule, and comprising an effector moiety, wherein the second epitope is different from the first epitope. An aspect of the invention is a composition comprising the first proteinaceous molecule and the second proteinaceous molecule of the invention. The invention also relates to an antibody-drug conjugate comprising the first proteinaceous molecule of the invention and an effector moiety. An aspect of the invention relates to a pharmaceutical composition comprising the composition or the antibody-drug conjugate of the invention, and optionally further comprising a pharmaceutically acceptable excipient. The invention also relates to the therapeutic combination or the composition or the antibody-drug conjugate or the pharmaceutical composition of the invention, for use as a medicament. The invention also relates to the therapeutic combination of the invention for use in the treatment or prophylaxis of a cancer.
Owner:SAPREME TECH BV

Preparation method and application of compound protein preparation

The invention provides a preparation method and application of a compound protein preparation, and the preparation method comprises the following steps: dissolving a protein matrix in deionized water, adjusting the pH value to 8.0-8.5, firstly adding an antioxidant, and then adding an oxidant and a reducing agent to obtain a protein coupling solution; dissolving the whey protein isolate in deionized water, adding a thickening agent, stirring, and cooling to room temperature to obtain a proteoglycan composite water phase; and mixing the protein coupling solution and the proteoglycan composite water phase according to a preset proportion, adding the oil phase, carrying out homogenization treatment to form a high internal phase emulsion, carrying out freeze drying, and crushing into particles to obtain the powdery protein pre-preparation. The structural stability of protein molecules is remarkably improved, and protein aggregation and sedimentation are reduced, so that the physical and chemical stability of the protein preparation in the storage and use processes is effectively improved, and the problem of insufficient structural stability in the prior art is solved.
Owner:TIMES FORMULAS FOR SPECIAL MEDICAL PURPOSES (SHENZHEN) CO LTD

Quenching type supramolecular fluorescent probe for pepsin detection as well as preparation method and application of quenching type supramolecular fluorescent probe

The invention discloses a quenching type supramolecular fluorescent probe for pepsin detection as well as a preparation method and application of the quenching type supramolecular fluorescent probe. The quenching type supramolecular fluorescent probe is obtained by virtue of supramolecular interaction of a luminous monomer and a protein molecule; wherein the protein molecule is selected from any one or a combination of more of human serum albumin, bovine serum albumin, casein, hemoglobin and collagen; the luminous monomer comprises an alpha-cyano styrene derivative. The quenching type supramolecular fluorescent probe is easy to synthesize, has good water solubility, can be used as a quenching type fluorescent probe of pepsin, has good selectivity and anti-interference capability, and can well meet the requirements of high sensitivity and accurate detection of pepsin.
Owner:SUZHOU DUSHU LAKE HOSPITAL (DUSHU LAKE HOSPITAL AFFILIATED TO SOOCHOU UNIV)

Enzyme-labeled secondary antibody polymer for immunohistochemical staining

The invention discloses an enzyme-labeled secondary antibody polymer for immunohistochemical staining. The enzyme-labeled secondary antibody polymer is formed by combining a secondary antibody and a polymer skeleton, the polymer is labeled by a labeling enzyme, the polymer skeleton is polymethylacrylic acid-2-hydroxyethyl ester, and the labeling enzyme is connected to the polymethylacrylic acid-2-hydroxyethyl ester through a coupling agent. According to the invention, polymethylacrylic acid-2-hydroxyethyl ester is used for modifying protein, so that the immunogenicity and antigenicity are reduced, the hydrolysis of protease can be weakened, and the solubility of protein molecules is improved. The enzyme-labeled secondary antibody polymer is applied to immunohistochemical staining and has high specificity and sensitivity.
Owner:PARKSON (GUANGZHOU) BIOLOGICAL PROD CO LTD

Compound water retention agent for food and preparation method of compound water retention agent

The invention discloses a compound water retention agent for food and a preparation method of the compound water retention agent, and mainly relates to the technical field of food additives. Compared with the prior art, sodium tripolyphosphate and sodium dihydrogen phosphate are used as composite phosphates, and are matched with the coordination effect of the enzyme preparation, glycerol, microcapsules, sodium carbonate, sodium citrate, maltodextrin, protein additive and thickening agent to maintain high water-retaining property, elasticity and tenderness. According to the invention, microcapsules prepared by taking glucomannan and the like as wall materials, taking casein as an emulsifier and taking grease core materials are also added, when the meat food is subjected to deep-frying processing, grease slowly released by the microcapsules can permeate into a meat protein network to weaken the cross-linking strength among protein molecules, and other components such as xanthan gum, guar gum and the like are matched, so that the meat food has a good deep-frying effect. Therefore, the hardness of the meat product is reduced, and high elasticity and tenderness are kept.
Owner:ZHEJIANG SHUOFENG FOOD INGREDIENTS CO LTD

System for producing liquid fertilizer by using fermentation waste liquid

The utility model relates to the field of waste recycling equipment, in particular to a system for producing a liquid fertilizer by using fermentation waste liquid. The system comprises: a heat exchanger for heating the fermentation waste liquid; the separation part comprises a centrifugal machine and a reverse osmosis membrane, a feed port of the centrifugal machine is communicated with a discharge port of the heat exchanger, a feed port of the reverse osmosis membrane is communicated with a discharge port of the centrifugal machine, and the reverse osmosis membrane comprises a concentrated phase discharge port; a material inlet of the mixing treatment part is respectively communicated with a material outlet of the centrifugal machine and a concentrated phase material outlet; according to the system, a large amount of high-value liquid fertilizer can be obtained only through the heat exchanger, the separation part and the mixing treatment part, the operation steps and the treatment cost of the system are reduced, in addition, precipitation of large protein molecules in organic matter is achieved through the heat exchanger and the centrifugal machine, and the overall loss of raw materials is low.
Owner:河北首朗新能源科技有限公司